This statistic depicts the average male body weight of U.S. adults aged 20 years and over from 1999 to 2016. According to the data, the average male body weight for those aged 40-59 years was 194.3 in 1999-2000 and increased to 200.9 as of 2015-2016.

In 2024, the mean average weight reported by men was 195 pounds, while the mean average weight for women was 164 pounds. This statistic shows the mean self-reported weight among U.S. adults from 1990 to 2024, by gender, in pounds.

Surveys in which U.S. adults report their current weight have shown that the share of those reporting they weigh 200 pounds or more has increased over the past few decades. In 2024, around 28 percent of respondents reported their weight as 200 pounds or more, compared to 15 percent in 1990. However, the same surveys show the share of respondents who report they are overweight has decreased compared to figures from 1990. What percentage of the U.S. population is obese? Obesity is an increasing problem in the United States that is expected to become worse in the coming decades. As of 2023, around one third of adults in the United States were considered obese. Obesity is slightly more prevalent among women in the United States, and rates of obesity differ greatly by region and state. For example, in West Virginia, around 41 percent of adults are obese, compared to 25 percent in Colorado. However, although Colorado is the state with the lowest prevalence of obesity among adults, a quarter of the adult population being obese is still shockingly high. The health impacts of being obese Obesity increases the risk of developing a number of health conditions including high blood pressure, heart disease, type 2 diabetes, and certain types of cancer. It is no coincidence that the states with the highest rates of hypertension are also among the states with the highest prevalence of obesity. West Virginia currently has the third highest rate of hypertension in the U.S. with 45 percent of adults with the condition. It is also no coincidence that as rates of obesity in the United States have increased so have rates of diabetes. As of 2022, around 8.4 percent of adults in the United States had been diagnosed with diabetes, compared to six percent in the year 2000. Obesity can be prevented through a healthy diet and regular exercise, which also increases overall health and longevity.

This statistic depicts the average body weight of U.S. men aged 20 years and over from 1999 to 2016, by ethnicity. According to the data, the average male body weight for those that identified as non-Hispanic white has increased from 192.3 in 1999-2000 to 202.2 in 2015-2016.

In 2024, around 40 percent of U.S. men reported weighing 200 pounds or more. This statistic shows the average self-reported weight among U.S. men from 1990 to 2024.

Data on normal weight, overweight, and obesity among adults aged 20 and over by selected population characteristics. Please refer to the PDF or Excel version of this table in the HUS 2019 Data Finder (https://www.cdc.gov/nchs/hus/contents2019.htm) for critical information about measures, definitions, and changes over time.

SOURCE: NCHS, National Health and Nutrition Examination Survey. For more information on the National Health and Nutrition Examination Survey, see the corresponding Appendix entry at https://www.cdc.gov/nchs/data/hus/hus19-appendix-508.pdf.

In 2024, around 16 percent of U.S. women reported weighing 200 pounds or more. This statistic shows the average self-reported weight among U.S. women from 1990 to 2024.

This statistic depicts the average body weight of U.S. females aged 20 years and over from 1999 to 2016, by ethnicity. According to the data, the average female body weight for those that identified as non-Hispanic white has increased from 161.9 in 1999-2000 to 170.9 in 2015-2016.

This statistic depicts the average body weight of U.S. females aged 20 years and over from 1999 to 2016, by age. According to the data, the average female body weight for those aged 40-59 years was 169.4 in 1999-2000 and increased to 176.4 as of 2015-2016.

BackgroundFew studies have examined weight transitions in contemporary multi-ethnic populations spanning early childhood through adulthood despite the ability of such research to inform obesity prevention, control, and disparities reduction.Methods and ResultsWe characterized the ages at which African American, Caucasian, and Mexican American populations transitioned to overweight and obesity using contemporary and nationally representative cross-sectional National Health and Nutrition Examination Survey data (n = 21,220; aged 2–80 years). Age-, sex-, and race/ethnic-specific one-year net transition probabilities between body mass index-classified normal weight, overweight, and obesity were estimated using calibrated and validated Markov-type models that accommodated complex sampling. At age two, the obesity prevalence ranged from 7.3% in Caucasian males to 16.1% in Mexican American males. For all populations, estimated one-year overweight to obesity net transition probabilities peaked at age two and were highest for Mexican American males and African American females, for whom a net 12.3% (95% CI: 7.6%-17.0%) and 11.9% (95% CI: 8.5%-15.3%) of the overweight populations transitioned to obesity by age three, respectively. However, extrapolation to the 2010 U.S. population demonstrated that Mexican American males were the only population for whom net increases in obesity peaked during early childhood; age-specific net increases in obesity were approximately constant through the second decade of life for African Americans and Mexican American females and peaked at age 20 for Caucasians.ConclusionsAfrican American and Mexican American populations shoulder elevated rates of many obesity-associated chronic diseases and disparities in early transitions to obesity could further increase these inequalities if left unaddressed.

IntroductionFeline obesity is a worldwide concern which has recently been formally classified as a disease by the veterinary community. Management involves invoking controlled weight loss by feeding a purpose-formulated food in restricted quantities and altering physical activity. Most weight loss studies conducted in cats have been undertaken in research cat colonies from single geographic locations. The aim of this multi-centre cohort study was to determine the efficacy of a short-term dietary weight loss intervention in overweight pet cats across a range of geographical locations globally.Materials and methodsA 3-month (median 13 weeks, inter-quartile range [IQR] 12–15 weeks) weight loss programme was conducted at 188 veterinary practices in 22 countries, and involving 730 cats, 413 of which completed the programme and had complete data available. All were fed commercially available dry or wet weight loss diets, and median energy intake was 53 kcal/kg BW0.711/day. The Royal Canin Ethics Committee approved the study, and owners gave informed consent. Owners completed behavioural questionnaires assessing begging, physical activity and quality of life (QOL). Linear mixed models were used to assess the respective influence of time, age, and initial body condition score (BCS) on weight loss and behavioural observations.ResultsAt baseline, median age was 72 months (range 12–200 months) and median BCS was 8 (range 7–9). In all, 402/413 cats (97%) lost weight (mean 10.6±6.3%) during the programme at a rate of 0.8 ±0.50%/week. Based upon owner questionnaires, activity and QOL improved (both P

Maternal obesity has been associated with a higher risk of pregnancy-related complications in mothers and offspring; however, effective interventions have not yet been developed. We tested two common interventions, calorie restriction and pravastatin administration, during pregnancy in a rhesus macaque model with the hypothesis that these interventions would normalize metabolic dysregulation in pregnant mothers leading to an improvement in infant metabolic and cognitive/social development. A total of 19 obese mothers were assigned to either one of the two intervention groups (n=5 for calorie restriction; n=7 for pravastatin) or an obese control group (n=7) with no intervention, and maternal gestational samples and postnatal infant samples were compared with lean control mothers (n=6). Gestational calorie restriction normalized one-carbon metabolism dysregulation in obese mothers but altered energy metabolism in their offspring. Although administration of pravastatin during pregnancy tended to normalize blood cholesterol in the mothers, it potentially impacted the gut microbiome and kidney function of their offspring. In the offspring, both calorie restriction and pravastatin administration during pregnancy tended to normalize the activity of AMPK in the brain at 6 months, and while results of the Visual Paired-Comparison test, which measures infant recognition memory, were not significantly impacted by either of the interventions, gestational pravastatin administration, but not calorie restriction, tended to normalize anxiety assessed by the Human Intruder test. Although the two interventions tested in a non-human primate model led to some improvements in metabolism and/or infant brain development, negative impacts were also found in both mothers and infants. Our study emphasizes the importance of assessing gestational interventions for maternal obesity on both maternal and offspring long-term outcomes. Methods Study population Pregnant female rhesus macaques (Macaca mulatta) from an indoor breeding colony at the California National Primate Research Center with appropriate social behavior and previous successful pregnancies were enrolled. Animal handling was approved by the UC Davis Institutional Animal Care and Use Committee (IACUC) (#19299). A qualitative real-time PCR assay (Jimenez & Tarantal, 2003) was used to identify mothers with male fetuses to include in this study. Since obesity is defined as subjects with body fat above 30% for women, according to guidelines from the American Society of Bariatric Physicians, American Medical Association, and in some publications (Okorodudu et al., 2010; Shah & Braverman, 2012), a Body Condition Score (BCS) of 3.5 (32.8 % body fat on average (Summers et al., 2012)) was used as the cutoff. Therefore, mothers with BCS of 3.5 and above were categorized as obese. Obese mothers were randomly assigned to the Obese Control (OC) group, OR group (received calorie Restriction), or OP group (received Pravastatin). Mothers with BCS of 2.5 and below were assigned to the Lean Control (LC) group. The unbalanced sample size was because some mothers were removed from the analyses due to fetal deaths for unknown reasons, misidentification of a female fetus, different timing for study enrollment, or technical issues upon collecting samples. The number of animals was six for the LC, seven for the OC, five for the OR, and seven for the OP groups. Feeding, rearing, and interventions Adult female animals were provided monkey diet (High Protein Primate Diet Jumbo #5047; LabDiet, St. Louis, MO, USA) twice a day between 6–9 am and 1–3 pm. The calories were provided as 56% from carbohydrates, 30% from protein, and 13% from. Mothers in the LC, OC, and OP groups were fed nine biscuits twice a day once pregnancy was confirmed. Mothers in the OR group received a restricted supply of food once the pregnancy was detected and was maintained throughout pregnancy. The food restriction was set such that the average total weight increase would be 8% body weight from the last day before conception because the recommended total weight gain in the 2nd and 3rd trimesters is 5-9 kg for the average US woman with obesity who weighs 80 kg and is 1.6 m in height (Body Mass Index of 30), according to the Institute of Medicine 2009 guidelines (Institute of Medicine and National Research Council, 2009). During nursing of infants older than 4 months, all mothers were provided twelve biscuits. Fresh produce was provided biweekly, and water was provided ad libitum for all mothers. Mothers in the OP group were given pravastatin sodium (ApexBio Technology, Houston, TX, USA) at 20 mg/kg body weight prepared in a neutralized syrup (20 mg/mL sodium bicarbonate dissolved in a fruit-flavored syrup (Torani, San Leandro, CA, USA)) once a day from the time pregnancy was confirmed until delivery. The caloric value of the administration was made so as not to influence body weight or skew nutritional value of the diet among all treatment groups. Both interventions were applied only during gestation. Although most mothers were allowed to deliver naturally, cesarean delivery was performed for fetal indications when recommended by veterinarians (2 for each of the LC and OC groups, and 1 for the OP group). These mothers did not accept their infant following birth, so foster mothers were provided. Sample Collection and pre-processing prior to sample storage The animal caretakers and researchers who collected samples were blinded for group assignment by coding all animals by IDs. The collected biological samples were randomized by using random numbers and the group assignment was blinded during the data collection. Both mothers (during pregnancy) and infants were weighed every week. One day before sample collection, food was removed 30 min after the afternoon feeding, and biological samples were collected prior to the morning feeding. To collect biological samples, animals were anesthetized using 5–30 mg/kg ketamine or 5–8 mg/kg telazol. Both maternal and infant blood was collected using 5 mL lavender top (EDTA) tubes (Monoject, Cardinal Health, Dublin, OH, USA) and urine was collected from the bladder by ultrasound-guided transabdominal cystotomy using a 22-gauge needle and stored in a 15 mL Falcon tube. A placental sample was collected at GD150 transabdominally under ultrasound guidance using an 18-gauge needle attached to a sterile syringe. Sample processing was as previously described in (Hasegawa et al., 2022). Necropsy was conducted between 9:30 am–1:30 pm. First, infants at the age of PD180 were fasted and anesthetized with ketamine, and plasma and urine were collected. Then, euthanasia was performed with 120 mg/kg pentobarbital, followed by heparin injection, clamping of the descending aorta, and flushing with saline until clear. The kidney and brain (amygdala, hippocampus, hypothalamus, and prefrontal cortex) were collected, weighed, and immediately frozen on dry ice or liquid nitrogen to store at -80 °C until further analyses. Metabolite extraction and analysis by 1H NMR, and measurement of insulin, cholesterol, cytokine, and cortisol Detailed procedures were previously described (Hasegawa et al., 2022). Briefly, plasma and urine samples were filtered using Amicon Ultra Centrifugal Filter (3k molecular weight cutoff; Millipore, Billerica, MA, USA), and the supernatant was used for analysis. For both the placental and brain tissue samples, polar metabolites were extracted using our previously reported method (Hasegawa et al., 2020). A total of 180 μL of sample (tissue extract or filtered urine or serum) was transferred to 3 mm Bruker NMR tubes (Bruker, Billerica, MA, USA). Within 24 h of sample preparation, all 1H NMR spectra were acquired using the noesypr1d pulse sequence on a Bruker Avance 600 MHz NMR spectrometer (Bruker, Billerica, MA, USA) (O’Sullivan et al., 2013). Chenomx NMRSuite (version 8.1, Chenomx Inc., Edmonton, Canada) (Weljie et al., 2006) was used to identify and quantify metabolites. Heparin-treated plasma samples were used to measure insulin and 17 cytokines and chemokines (hs-CRP, Granulocyte-macrophage colony-stimulating factor, IFN-γ, TNF-α, transforming growth factor-α, monocyte chemoattractant protein-1, macrophage inflammatory protein-1β (MIP-1β), and interleukin (IL)-1β, IL-1 receptor antagonist (IL-1ra), IL-2, IL-6, IL-8, IL-10, IL-12/23 p40, IL-13, IL-15, and IL-17A) using a multiplex Bead-Based Kit (Millipore) on a Bio-Plex 100 (Bio-rad, Hercules, CA) following the manufacturer’s protocol. For each sample, a minimum of fifty beads per region were collected and analyzed with Bio-Plex Manager software using a 5-point standard curve with immune marker quantities extrapolated based on the standard curve. Two samples were removed for analysis of TNF-α and IL-1ra as technical errors (both from Animal ID 1132103: 895.2 and 1115.1 pg/mL at gestational days (GD) 90; 510.8 and 617.2 pg/mL at GD120, respectively). Plasma cholesterol level was measured by Clinical Laboratory Diagnostic Product (OSR6116) on Beckman Coulter AU480 (Beckman Coulter, Brea, CA). Infant plasma cortisol level at PD110 was assessed as previously described (Vandeleest et al., 2019; Walker et al., 2018). In short, infants were transferred to a test room at 9 am and blood was drawn at 11 am (Sample 1), followed by another blood collection at 4 pm (Sample 2) and intramuscular injection of 500 μg/kg dexamethasone (Dex) (American Regent Laboratories, Inc., Shirley, NY). On the next day, a blood sample was collected at 8:30 am (Sample 3), and then 2.5 IU of adrenocorticotropic hormone (Amphastar Pharmaceuticals, Inc., Rancho Cucamonga, CA) was injected intramuscularly. The last blood was collected (Sample 4) 30 min after adrenocorticotropic hormone injection. The collected blood samples were processed and stored, and cortisol concentration was assessed by a chemiluminescent assay on the ADVIA Centaur CP platform

Average composition of diets for weight loss.

This statistic depicts the average body mass index (BMI) of U.S. adults aged 20 years and over as of 2016, by gender. According to the data, the average male BMI has increased from 27.8 in 1999-2000 to 29.1 as of 2015-2016.

Additional file 3: Table S2. Male and female weight-for-height mean and SD by centimeter from 50–140 cm in males and 50–134 cm in females.

Caloric restriction (CR) slows biological aging and prolongs healthy lifespan in model organisms. Findings from the CALERIE randomized, controlled trial of long-term CR in healthy, non-obese humans (NCT00427193) broadly support a similar pattern of effects in humans. To expand our understanding of the molecular pathways and biological processes underpinning CR effects in humans, we generated a series of genomic datasets from stored biospecimens collected from n=218 participants during the trial. These data constitute the first genomic data resource for a randomized controlled trial of an intervention targeting the biology of aging. Datasets include whole-genome SNP genotypes, and three-timepoint-longitudinal DNA methylation, mRNA, and small RNA datasets generated from blood, skeletal muscle, and adipose tissue samples (total sample n=2327). The CALERIE Genomic Data Resource described in this article is available from the Aging Research Biobank. This multi-tissue, multi-omic, longitudinal data resource has great potential to advance translational geroscience. Methods CALERIE Phase 2 was a multi-center, randomized controlled trial conducted at three clinical centers in the United States8 (ClinicalTrials.gov Identifier: NCT00427193). It aimed to evaluate the time-course effects of 25% CR (that is, intake 25% below the individual’s baseline level) over a 2-yr period in healthy adults (men aged 21–50 yr, premenopausal women aged 21–47 yr) with BMI in the normal weight or slightly overweight range (BMI 22.0–27.9 kg m−2). The study protocol was approved by Institutional Review Boards at three clinical centers (Washington University School of Medicine, St Louis, MO, USA; Pennington Biomedical Research Center, Baton Rouge, LA, USA; Tufts University, Boston, MA, USA) and the coordinating center at Duke University (Durham, NC, USA). All study participants provided written informed consent. Nongenomic data were obtained from the CALERIE Biorepository (https://calerie.duke.edu/apply-samples-and-data-analysis). Oversight of our study was performed by the Institutional Review Board of Columbia University Irving Medical Center AAAS2948. Extending CALERIE phase I in both scale and duration, CALERIE recruited a total of 220 subjects and assigned them in a 2:1 allocation to a CR treatment group or ad libitum (AL) control arm. Subjects were randomly assigned to CR or AL groups stratified on study site, sex, and body mass index. Participants in the CR group were assigned to a protocol designed to result in a 25% reduction in caloric intake relative to estimated energy requirements at enrollment. CR participants received an intensive behavioral intervention that included individual and group sessions, a meal provision phase, digital assistants to monitor caloric intake, and training in portion estimation and other nutrition and behavioral topics. Adherence was assessed using measures of energy expenditure using the doubly-labeled water method as well as expected changes in body composition. The duration of the study for both CR and AL participants was 2 years. Throughout the 2-year study duration, starting at baseline prior to randomization and recurring at months 1, 3, 6, 9, 12, 18, and 24, participants were evaluated for a range of pre-specified anthropometric, psychological, behavioral, and physiological outcomes. Blood samples were collected every six months. At baseline, 12-months, and 24-months, whole blood and samples were collected and banked. In addition, a subset of participants agreed to biopsies of adipose and muscle tissue at baseline, 12-months, and 24-months. From these samples, SNP-based genotypes, DNA methylation, mRNA, and small RNAs were assayed. Here, we describe these datasets and provide an overview of this data resource (Fig. 1). More details about the CALERIE trial, including study protocols and ongoing and published research, are available at https://calerie.duke.edu. Data can be accessed through the Aging Research Biobank (https://agingresearchbiobank.nia.nih.gov/studies/calerie/). Data use is restricted to non-commercial use in studies to determine factors that affect age-related conditions. Biospecimens are available, but limited to research on the effects that caloric restriction may have on aging and aging-related diseases. Applications for data access include a brief summary of the research question and intended analysis and proof of IRB approval for the project.

In 2022, the U.S. states with the highest rates of obesity among women were Tennessee, Louisiana, and Mississippi. At that time, almost 43 percent of women in Tennessee were considered obese. The states with the highest rates of obesity among men are West Virginia, Kentucky, and Oklahoma. Obesity: Women vs. men As of 2022, women in the United States had slightly higher rates of obesity than men. At that time, around 34.1 percent of women were considered obese, compared to 32.6 percent of men. Rates of obesity among both men and women are higher in the United States than any other OECD country, with high-calorie diets, often from fast food and sugary drinks, and large food portion sizes being partly to blame. In 2023, the mean self-reported weight among men in the United States was 199 pounds, while women reported weighing an average of 164 pounds. Which state is the most obese? As of 2022, West Virginia had the highest prevalence of adult obesity in the United States, with around 41 percent of the population considered obese. Following West Virginia, Louisiana, Oklahoma, and Mississippi, had some of the highest rates of obesity in the country. Colorado had the lowest share of adults who were obese at that time, but still, a quarter of adults in the state were obese. West Virginia is also the state with the highest prevalence of obesity among high school students, with 27 percent of high schoolers considered obese in 2021. Obesity in childhood is associated with obesity as adults, as well as mental health problems such as anxiety and depression.

Of the forty* men who have been elected to the office of U.S. president, the average weight of U.S. presidents has been approximately 189lbs (86kg). The weight range has been between 122lbs (55kg) and 332lbs (151kg), meaning that the heaviest president, William Howard Taft, was almost three times as heavy as the lightest president, James Madison (who was also the shortest president). Although Taft weighed over 300lbs during his presidency in 1909, he did implement a fitness and dietary regimen in the 1920s, that helped him lose almost 100lbs (45kg) before his death due to cardiovascular disease in 1930. Increase over time The tallest ever president, Abraham Lincoln (who was 6'4"), actually weighed less than the presidential average, and also less than the average adult male in the U.S. in 2018. It is important to note that the average weight of U.S. males has gradually increased in the past two decades, with some studies suggesting that it may have even increased by 15lbs (7kg) since the 1980s. The presidential averages have also increased over time, as the first ten elected presidents had an average weight of 171lbs (78kg), while the average weight of the ten most recent is 194lbs (88kg). Recent presidents In recent years, the heaviest president has been Donald Trump, who weighed 237lbs (108kg) during his first term in office; however medical reports published in June 2020 show that he gained 7lbs (3kg) during this term. There was also controversy in 2018, when it appeared that Trump's official height had been increased from 6'2" to 6'3", which many speculated was done to prevent him from being categorized as "obese" (according to his BMI). In the past half century, George H. W. Bush and Bill Clinton were the only other presidents to have weighed more than the presidential average, although both men were also 6'2" (188cm) tall. President Joe Biden weighs below the presidential average, at 177lbs (81kg).

West Virginia, Mississippi, and Arkansas are the U.S. states with the highest percentage of their population who are obese. The states with the lowest percentage of their population who are obese include Colorado, Hawaii, and Massachusetts. Obesity in the United States Obesity is a growing problem in many countries around the world, but the United States has the highest rate of obesity among all OECD countries. The prevalence of obesity in the United States has risen steadily over the previous two decades, with no signs of declining. Obesity in the U.S. is more common among women than men, and overweight and obesity rates are higher among African Americans than any other race or ethnicity. Causes and health impacts Obesity is most commonly the result of a combination of poor diet, overeating, physical inactivity, and a genetic susceptibility. Obesity is associated with various negative health impacts, including an increased risk of cardiovascular diseases, certain types of cancer, and diabetes type 2. As of 2022, around 8.4 percent of the U.S. population had been diagnosed with diabetes. Diabetes is currently the eighth leading cause of death in the United States.

In 2022, men aged 55 to 64 years had an average body mass index (BMI) of 29 kg/m2 and women in the same age group had a BMI of 28.8 kg/m2, the highest mean BMI across all the age groups. Apart from individuals aged 16 to 24 years, every demographic in England had an average BMI which is classified as overweight.An increasing problem It is shown that the mean BMI of individuals for both men and women has been generally increasing year-on-year in England. The numbers show in England, as in the rest of the United Kingdom (UK), that the prevalence of obesity is an increasing health problem. The prevalence of obesity in women in England has increased by around nine percent since 2000, while for men the share of obesity has increased by six percent. Strain on the health service Being overweight increases the chances of developing serious health problems such as diabetes, heart disease and certain types of cancers. In the period 2019/20, England experienced over 10.7 thousand hospital admissions with a primary diagnosis of obesity, whereas in 2002/03 this figure was only 1,275 admissions. Furthermore, the number of bariatric surgeries taking place in England, particularly among women, has significantly increased over the last fifteen years. In 2019/20, over 5.4 thousand bariatric surgery procedures were performed on women and approximately 1.3 thousand were carried out on men.